EE295 Indirect Treatment Comparison and Cost-Minimization Analysis of Riociguat Versus Selexipag in Patients With Pulmonary Arterial Hypertension

Abstract

Authors

E Ornstová J Tužil K Chadimova T Mlcoch T Doležal

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×